Search research articles
Contact Us
Filters
Showing results (171-180 of 218) with videos related to
Page
of 22
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
E Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.
Nature Genetics
|
January 22, 2013
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
Brain Pathology (Zurich, Switzerland)
|
May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification
Cynthia Hawkins, Kenneth Aldape, David Capper, et al.
Journal of the National Cancer Institute
|
October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Nature Biotechnology
|
December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
Jinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Acta Neuropathologica
|
January 31, 2020
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Cancer Discovery
|
August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expression
James P Sullivan, Brian V Nahed, Marissa W Madden, et al.
EMBO Molecular Medicine
|
May 1, 2010
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata, Sara Akhavanfard, Serena S David, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 218) with videos related to
Sort By:
Page
of 22
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
E Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.
Nature Genetics
|
January 22, 2013
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
Brain Pathology (Zurich, Switzerland)
|
May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification
Cynthia Hawkins, Kenneth Aldape, David Capper, et al.
Journal of the National Cancer Institute
|
October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Nature Biotechnology
|
December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
Jinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Acta Neuropathologica
|
January 31, 2020
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Cancer Discovery
|
August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expression
James P Sullivan, Brian V Nahed, Marissa W Madden, et al.
EMBO Molecular Medicine
|
May 1, 2010
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata, Sara Akhavanfard, Serena S David, et al.
Page
of 22